Accessibility settings

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/87156, first published .
Tripterygium Glycoside Tablets Combined With Conventional Synthetic Disease-Modifying Antirheumatic Drugs for Treating Rheumatoid Arthritis: Protocol for a Prospective, Multicenter, Open-Label Randomized Controlled Trial

Tripterygium Glycoside Tablets Combined With Conventional Synthetic Disease-Modifying Antirheumatic Drugs for Treating Rheumatoid Arthritis: Protocol for a Prospective, Multicenter, Open-Label Randomized Controlled Trial

Tripterygium Glycoside Tablets Combined With Conventional Synthetic Disease-Modifying Antirheumatic Drugs for Treating Rheumatoid Arthritis: Protocol for a Prospective, Multicenter, Open-Label Randomized Controlled Trial

Authors of this article:

Liu Lv1 Author Orcid Image ;   Tuoran Wang2 Author Orcid Image ;   Jing Lv3 Author Orcid Image ;   Chunping Liu1 Author Orcid Image ;   Luming Zhao1 Author Orcid Image ;   Yu Zhou2 Author Orcid Image

Liu Lv   1 * , MM ;   Tuoran Wang   2 * , MM ;   Jing Lv   3 , MM ;   Chunping Liu   1 , MM ;   Luming Zhao   1 , MM ;   Yu Zhou   2 , MM

1 Department of Rheumatology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China

2 Acupuncture and Moxibustion Hospital, Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, China

3 Department of Rheumatology, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, China

*these authors contributed equally

Corresponding Author:

  • Yu Zhou, MM
  • Acupuncture and Moxibustion Hospital, Institute of Acupuncture and Moxibustion
  • China Academy of Chinese Medical Sciences
  • No. 16 Nanxiaojie, Dongzhimennei, Dongcheng District
  • Beijing
  • China
  • Phone: 86 13520302630
  • Email: 13520302630@163.com